Form 4 · Filed Jun 4, 2026, 08:14 PM UTC
LXRX/LEXICON PHARMACEUTICALS, INC.
Swain Judith L — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | M | other | 89,312 | $0 | — | 174,486 |
| Jun 3, 2026 | M | other | 89,312 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001062822-26-000108